ARPC5L | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	37 studies	47% ± 17%	Explore
B cell	29 studies	29% ± 9%	Explore
CD8-positive, alpha-beta T cell	29 studies	36% ± 18%	Explore
endothelial cell	24 studies	31% ± 12%	Explore
CD4-positive, alpha-beta T cell	23 studies	28% ± 16%	Explore
T cell	21 studies	31% ± 10%	Explore
memory B cell	18 studies	28% ± 9%	Explore
regulatory T cell	18 studies	32% ± 11%	Explore
gamma-delta T cell	17 studies	32% ± 13%	Explore
mature NK T cell	16 studies	41% ± 14%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	44% ± 18%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	48% ± 17%	Explore
naive B cell	14 studies	22% ± 7%	Explore
plasmacytoid dendritic cell	13 studies	32% ± 10%	Explore
basal cell	13 studies	29% ± 14%	Explore
plasma cell	12 studies	37% ± 15%	Explore
epithelial cell	12 studies	36% ± 18%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	35% ± 12%	Explore
plasmablast	10 studies	46% ± 21%	Explore
ciliated cell	10 studies	34% ± 16%	Explore
mucosal invariant T cell	10 studies	31% ± 8%	Explore
endothelial cell of lymphatic vessel	9 studies	25% ± 6%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	29% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	33% ± 15%	Explore
endothelial cell of artery	9 studies	25% ± 7%	Explore
endothelial cell of vascular tree	9 studies	38% ± 10%	Explore
secretory cell	8 studies	29% ± 16%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	32% ± 7%	Explore
vein endothelial cell	8 studies	26% ± 11%	Explore
dendritic cell	7 studies	33% ± 18%	Explore
classical monocyte	7 studies	25% ± 10%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	42% ± 19%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	7 studies	22% ± 3%	Explore
T follicular helper cell	7 studies	23% ± 4%	Explore
type I pneumocyte	6 studies	27% ± 11%	Explore
type II pneumocyte	6 studies	27% ± 14%	Explore
capillary endothelial cell	6 studies	24% ± 7%	Explore
fibroblast	6 studies	21% ± 7%	Explore
abnormal cell	6 studies	23% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	27% ± 7%	Explore
exhausted T cell	5 studies	54% ± 8%	Explore
conventional dendritic cell	5 studies	33% ± 18%	Explore
pericyte	5 studies	19% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	34% ± 13%	Explore
club cell	4 studies	25% ± 11%	Explore
pancreatic A cell	4 studies	32% ± 9%	Explore
non-classical monocyte	4 studies	35% ± 13%	Explore
immature B cell	4 studies	24% ± 9%	Explore
precursor B cell	4 studies	32% ± 6%	Explore
pro-B cell	4 studies	28% ± 2%	Explore
innate lymphoid cell	4 studies	34% ± 14%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	23% ± 3%	Explore
goblet cell	4 studies	25% ± 8%	Explore
T-helper 17 cell	4 studies	32% ± 23%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	41% ± 17%	Explore
deuterosomal cell	3 studies	21% ± 8%	Explore
squamous epithelial cell	3 studies	40% ± 23%	Explore
leukocyte	3 studies	36% ± 11%	Explore
hematopoietic precursor cell	3 studies	40% ± 14%	Explore
neuron	3 studies	29% ± 14%	Explore
retinal ganglion cell	3 studies	62% ± 23%	Explore
smooth muscle cell	3 studies	18% ± 1%	Explore
placental villous trophoblast	3 studies	35% ± 3%	Explore
lymphocyte	3 studies	40% ± 14%	Explore
monocyte	3 studies	22% ± 5%	Explore
serous secreting cell	3 studies	15% ± 0%	Explore
germinal center B cell	3 studies	38% ± 9%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	43% ± 6%	Explore
macrophage	3 studies	23% ± 6%	Explore
glutamatergic neuron	3 studies	39% ± 16%	Explore
enteroendocrine cell	3 studies	30% ± 13%	Explore
transit amplifying cell	3 studies	19% ± 2%	Explore
keratinocyte	3 studies	33% ± 19%	Explore
T-helper 1 cell	3 studies	37% ± 16%	Explore
double negative thymocyte	3 studies	42% ± 17%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	15 studies	29% ± 8%	Explore
lung	12 studies	26% ± 13%	Explore
lymph node	5 studies	21% ± 4%	Explore
pancreas	4 studies	30% ± 8%	Explore
placenta	4 studies	24% ± 6%	Explore
breast	4 studies	19% ± 2%	Explore
intestine	4 studies	21% ± 8%	Explore
liver	4 studies	27% ± 11%	Explore
uterus	3 studies	30% ± 13%	Explore
prostate	3 studies	23% ± 7%	Explore
brain	3 studies	26% ± 9%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
stomach	100%	2363.34	359 / 359	100%	46.56	286 / 286
uterus	100%	1548.32	170 / 170	100%	74.69	459 / 459
esophagus	100%	3113.85	1444 / 1445	100%	47.84	183 / 183
lung	100%	3454.84	577 / 578	100%	53.29	1155 / 1155
intestine	100%	2521.77	966 / 966	100%	52.82	526 / 527
bladder	100%	2032.05	21 / 21	100%	59.26	503 / 504
skin	100%	3917.11	1809 / 1809	100%	36.26	471 / 472
liver	100%	2143.46	226 / 226	100%	28.58	405 / 406
brain	100%	3544.19	2634 / 2642	100%	38.61	705 / 705
thymus	100%	2190.84	652 / 653	100%	46.23	604 / 605
adrenal gland	100%	3752.54	258 / 258	100%	47.12	229 / 230
prostate	100%	2053.58	245 / 245	99%	40.83	499 / 502
breast	100%	2239.32	459 / 459	99%	51.51	1111 / 1118
kidney	100%	2536.83	89 / 89	99%	24.05	895 / 901
ovary	98%	1083.24	176 / 180	100%	40.28	430 / 430
pancreas	96%	1075.27	316 / 328	99%	50.36	177 / 178
lymph node	0%	0	0 / 0	100%	110.31	29 / 29
spleen	100%	4449.89	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	68.57	45 / 45
ureter	0%	0	0 / 0	100%	143.85	1 / 1
adipose	100%	2393.05	1203 / 1204	0%	0	0 / 0
muscle	100%	2503.67	802 / 803	0%	0	0 / 0
blood vessel	99%	1699.70	1324 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	99%	26.49	79 / 80
heart	97%	2235.41	831 / 861	0%	0	0 / 0
peripheral blood	93%	2684.22	863 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0034314	Biological process	Arp2/3 complex-mediated actin nucleation
GO_0030833	Biological process	regulation of actin filament polymerization
GO_0008150	Biological process	biological_process
GO_0016477	Biological process	cell migration
GO_0098978	Cellular component	glutamatergic synapse
GO_0070062	Cellular component	extracellular exosome
GO_0005885	Cellular component	Arp2/3 protein complex
GO_0005737	Cellular component	cytoplasm
GO_0005925	Cellular component	focal adhesion
GO_0051015	Molecular function	actin filament binding
GO_0005515	Molecular function	protein binding
GO_0003674	Molecular function	molecular_function

IV. Literature review

[source]

Gene name	ARPC5L
Protein name	Actin-related protein 2/3 complex subunit 5 Actin-related protein 2/3 complex subunit 5-like protein (Arp2/3 complex 16 kDa subunit 2) (ARC16-2)
Synonyms	hCG_29225
Description	FUNCTION: May function as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. FUNCTION: Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Arp2/3 complex plays a critical role in the control of cell morphogenesis via the modulation of cell polarity development. .; FUNCTION: May function as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. .
Accessions	ENST00000259477.6 Q9BPX5 A0A024R897 ENST00000353214.6

ARPC5L report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review